A recent in vitro study on ankylosing spondylitis found that KLF4 downregulates FGF21 via the SIRT1/NF-κB/p53 signaling pathway to activate LPS-induced inflammatory damage and oxidative stress in ATDC5 cells [50]. This evidence concerns the gene TP53 and ankylosing spondylitis.